Mastodawn

Do you work in or represent the pharmaceutical or medical technology industries?

💡Take our survey and help us understand perceptions and experiences with blood testing: https://qualicis.eu.qualtrics.com/jfe/form/SV_cBxkoCMwg0nxO1o?Partner=WEB

Project‑COMFORT is exploring blood microsampling as a practical alternative to traditional blood draws.

@IHIEurope

#MedicalTechnology #PharmaIndustry #InnovationInHealth #BloodMicrosampling

i2notes Mar 14

The Impact of War on Medicine Prices: A Global Healthcare Challenge

War disrupts global supply chains, increases manufacturing costs, and creates shortages of essential medicines. These disruptions lead to rising drug prices worldwide, affecting hospitals, pharmacies, and patients.

#MedicinePrices #GlobalHealthcare #WarImpact #PharmaIndustry #DrugPriceInflation #HealthcareCrisis #MedicalSupply #PublicHealth #HealthcareEconomics #GlobalHealth

https://i2notes.wordpress.com/2026/03/14/war-impact-medicine-prices/

The Impact of War on Medicine Prices: A Global Healthcare Challenge

I2notes

Mathrubhumi English Mar 12

Medicine prices in India may rise 10–20% by March-end as Strait of Hormuz disruptions push up fuel, logistics and pharma manufacturing costs. https://english.mathrubhumi.com/news/money/india-pharma-price-hike-west-asia-crisis-x0wrpidp?utm_source=dlvr.it&utm_medium=mastodon #MedicinePrices #PharmaIndustry #IndiaPharma #HormuzCrisis

Mathrubhumi English Feb 25

The pharma giant has officially secured USFDA approval for its generic version of the seizure medication Brivaracetam. https://english.mathrubhumi.com/lifestyle/health/lupin-receives-usfda-approval-to-market-generic-seizure-medication-ep5lt1dc?utm_source=dlvr.it&utm_medium=mastodon #Lupin #PharmaIndustry #USFDA #StockMarketIndia #HealthcareNews

The-14 Feb 2

Why drug approval in Canada should not rely on foreign regulators
#Canada #Health #DrugApproval #PharmaIndustry #PublicHealth #FDA #EMA #HealthcarePolicy #PatientSafety #MedicalEthics #Regulation #BigPharma #HealthPolicy #Politics #EvidenceBasedMedicine
https://the-14.com/why-drug-approval-in-canada-should-not-rely-on-foreign-regulators/

Why drug approval in Canada should not rely on foreign regulators | The-14

Canada should not outsource drug approvals to the FDA or EMA without proof it improves safety, value, or access for patients, not just faster pharma profits.

The-14 Pictures